Deerfield Management Company as of March 31, 2019
Portfolio Holdings for Deerfield Management Company
Deerfield Management Company holds 93 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Pharma | 6.5 | $171M | 6.5M | 26.43 | |
| Homology Medicines | 5.6 | $145M | 5.2M | 27.73 | |
| Orchard Therapeutics Plc ads | 5.5 | $144M | 8.0M | 17.88 | |
| Horizon Pharma Plc convertible security | 5.0 | $131M | 116M | 1.13 | |
| Nevro Corp note 1.750% 6/0 | 3.9 | $101M | 100M | 1.01 | |
| Portola Pharmaceuticals | 3.5 | $91M | 2.6M | 34.70 | |
| Mylan Nv | 3.5 | $91M | 3.2M | 28.34 | |
| Aerie Pharmaceuticals | 2.9 | $76M | 1.6M | 47.50 | |
| Immunomedics | 2.8 | $73M | 3.8M | 19.21 | |
| Intersect Ent | 2.5 | $65M | 2.0M | 32.15 | |
| Acceleron Pharma | 2.2 | $59M | 1.3M | 46.57 | |
| Intercept Pharmas conv | 2.2 | $57M | 58M | 0.99 | |
| Anaptysbio Inc Common (ANAB) | 2.1 | $54M | 743k | 73.05 | |
| BioCryst Pharmaceuticals (BCRX) | 2.0 | $53M | 6.5M | 8.14 | |
| Myokardia | 2.0 | $52M | 997k | 51.99 | |
| Argenx Se (ARGX) | 1.9 | $49M | 394k | 124.84 | |
| Sarepta Therapeutics (SRPT) | 1.8 | $46M | 386k | 119.19 | |
| Diplomat Pharmacy | 1.6 | $41M | 7.0M | 5.81 | |
| Blueprint Medicines (BPMC) | 1.6 | $41M | 507k | 80.05 | |
| Axogen (AXGN) | 1.4 | $37M | 1.8M | 21.06 | |
| Alector (ALEC) | 1.4 | $37M | 2.0M | 18.72 | |
| Nevro (NVRO) | 1.4 | $36M | 580k | 62.51 | |
| Centene Corporation (CNC) | 1.4 | $35M | 667k | 53.10 | |
| Aclaris Therapeutics (ACRS) | 1.4 | $35M | 5.9M | 5.99 | |
| Brookdale Senior Living (BKD) | 1.3 | $34M | 5.2M | 6.58 | |
| Ra Pharmaceuticals | 1.3 | $34M | 1.5M | 22.40 | |
| Reata Pharmaceuticals Inc Cl A | 1.2 | $31M | 364k | 85.47 | |
| Fate Therapeutics (FATE) | 1.1 | $30M | 1.7M | 17.57 | |
| Vericel (VCEL) | 1.1 | $30M | 1.7M | 17.51 | |
| Select Medical Holdings Corporation (SEM) | 1.1 | $29M | 2.0M | 14.09 | |
| Kempharm Inc note 5.500% 2/0 | 1.1 | $29M | 65M | 0.44 | |
| Editas Medicine (EDIT) | 1.1 | $28M | 1.2M | 24.45 | |
| eHealth (EHTH) | 1.1 | $27M | 440k | 62.34 | |
| Natera (NTRA) | 1.1 | $27M | 1.3M | 20.62 | |
| Dexcom Inc dbcv 0.750% 5/1 | 1.0 | $27M | 20M | 1.34 | |
| Dfb Healthcare Acquistion Co unit 01/30/2023 | 1.0 | $25M | 2.5M | 10.15 | |
| Kiniksa Pharmaceuticals (KNSA) | 0.9 | $24M | 1.3M | 18.06 | |
| Xeris Pharmaceuticals | 0.9 | $24M | 2.4M | 10.04 | |
| Sientra | 0.9 | $23M | 2.7M | 8.58 | |
| Wright Medical Group Nv 2.25 20211115 | 0.8 | $21M | 14M | 1.55 | |
| Galapagos Nv- (GLPG) | 0.8 | $21M | 177k | 117.78 | |
| Exact Sciences Corp convertible/ | 0.8 | $21M | 15M | 1.37 | |
| Audentes Therapeutics | 0.7 | $19M | 494k | 39.02 | |
| Mirati Therapeutics | 0.7 | $19M | 252k | 73.30 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $19M | 650k | 28.62 | |
| Glaukos (GKOS) | 0.7 | $18M | 228k | 78.37 | |
| Ascendis Pharma A S (ASND) | 0.7 | $17M | 144k | 117.70 | |
| Addus Homecare Corp (ADUS) | 0.6 | $16M | 253k | 63.59 | |
| Universal Health Services (UHS) | 0.6 | $16M | 119k | 133.77 | |
| Wave Life Sciences (WVE) | 0.6 | $15M | 395k | 38.85 | |
| Anthem (ELV) | 0.6 | $15M | 53k | 286.98 | |
| Deciphera Pharmaceuticals (DCPH) | 0.5 | $14M | 608k | 23.21 | |
| Morphosys (MOR) | 0.5 | $14M | 600k | 22.72 | |
| Arvinas Ord (ARVN) | 0.5 | $14M | 921k | 14.76 | |
| Dbv Technologies S A (DBVT) | 0.5 | $13M | 1.7M | 7.71 | |
| Molina Healthcare (MOH) | 0.5 | $12M | 86k | 141.97 | |
| Syros Pharmaceuticals | 0.4 | $12M | 1.3M | 9.14 | |
| Shockwave Med (SWAV) | 0.4 | $10M | 312k | 33.47 | |
| Invitae (NVTAQ) | 0.4 | $9.7M | 413k | 23.42 | |
| Allogene Therapeutics (ALLO) | 0.4 | $9.4M | 327k | 28.91 | |
| Ardelyx (ARDX) | 0.3 | $9.2M | 3.3M | 2.80 | |
| Ptc Therapeutics I (PTCT) | 0.3 | $8.9M | 237k | 37.64 | |
| Synlogic | 0.3 | $8.4M | 1.1M | 7.59 | |
| Rhythm Pharmaceuticals (RYTM) | 0.3 | $8.0M | 291k | 27.41 | |
| Nuvasive Inc note 2.250% 3/1 | 0.3 | $7.8M | 7.0M | 1.11 | |
| Inspire Med Sys (INSP) | 0.3 | $7.9M | 139k | 56.78 | |
| Athenex | 0.3 | $7.6M | 622k | 12.25 | |
| Alimera Sciences | 0.2 | $6.4M | 6.1M | 1.06 | |
| Teligent Inc New bond | 0.2 | $6.4M | 9.6M | 0.67 | |
| Pfenex | 0.2 | $5.7M | 918k | 6.18 | |
| Axovant Sciences | 0.2 | $5.3M | 4.0M | 1.33 | |
| Rocket Pharmaceuticals (RCKT) | 0.2 | $4.9M | 280k | 17.54 | |
| Clovis Oncology Inc note 2.500% 9/1 | 0.2 | $4.7M | 5.0M | 0.93 | |
| Neos Therapeutics | 0.2 | $4.7M | 1.8M | 2.61 | |
| Aeglea Biotherapeutics | 0.1 | $4.0M | 500k | 8.05 | |
| Flamel Technologies Sa (AVDL) | 0.1 | $3.9M | 2.7M | 1.44 | |
| Meiragtx Holdings (MGTX) | 0.1 | $4.0M | 234k | 17.23 | |
| Aac Holdings | 0.1 | $3.6M | 1.9M | 1.84 | |
| Itamar Med | 0.1 | $3.6M | 314k | 11.61 | |
| Alpine Immune Sciences (ALPN) | 0.1 | $3.3M | 476k | 6.86 | |
| Constellation Pharmceticls I | 0.1 | $3.4M | 253k | 13.55 | |
| Osmotica Pharmaceuticals (RVLPQ) | 0.1 | $3.0M | 846k | 3.60 | |
| Harpoon Therapeutics | 0.1 | $2.7M | 285k | 9.47 | |
| Tandem Diabetes Care (TNDM) | 0.1 | $2.3M | 36k | 63.49 | |
| Neuronetics (STIM) | 0.1 | $2.4M | 159k | 15.25 | |
| Savara (SVRA) | 0.1 | $1.8M | 250k | 7.37 | |
| Eyenovia Inc equity (EYEN) | 0.1 | $1.8M | 300k | 5.99 | |
| Teligent Inc note 3.750 12/1 | 0.1 | $1.7M | 1.7M | 0.97 | |
| Menlo Therapeutics | 0.1 | $1.6M | 199k | 7.85 | |
| Orthopediatrics Corp. (KIDS) | 0.1 | $1.4M | 32k | 44.22 | |
| Melinta Therapeutics | 0.1 | $1.3M | 357k | 3.55 | |
| Proteon Therapeutics | 0.0 | $612k | 1.2M | 0.50 | |
| Eyepoint Pharmaceuticals | 0.0 | $406k | 227k | 1.79 |
